Article
Co-occurrence of amikacin-resistant and -susceptible Mycobacterium tuberculosis isolates in clinical samples from Beijing, China.
The Journal of antimicrobial chemotherapy - 1 Jul 2013
Zhang Xiaobing, Zhao Bing, Huang Hairong, Zhu Yafang, Peng Junping, Dai Guangming, Jiang Guanglu, Liu Liguo, Zhao Yanlin, Jin Qi
Abstract excerpt
OBJECTIVES: This study examined the phenomenon of heteroresistance in Mycobacterium tuberculosis clinical isolates obtained from retreated patients in Beijing, China between 2006 and 2011. METHODS: The iPLEX Gold assay platform was used to determine the prevalence of heteroresistance to injectable second-line drugs (amikacin, kanamycin and capreomycin) in resistant isolates. RESULTS: Heteroresistance was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
